Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 1, 2014, Pages 61-71

  Münzer, Patrick ^a   Borst, Oliver ^a   Walker, Britta ^a   Schmid, Evi ^a   Feijge, Marion A H ^b   Cosemans, Judith M E M ^b   Chatterjee, Madhumita ^a   Schmidt, Eva Maria ^a   Schmidt, Sebastian ^a   Towhid, Syeda T ^a   Leibrock, Christina ^a   Elvers, Margitta ^a,e   Schaller, Martin ^a   Seizer, Peter ^a   Ferlinz, Klaus ^c   May, Andreas E ^a   Gulbins, Erich ^d   Heemskerk, Johan W M ^b   Gawaz, Meinrad ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Acid sphingomyelinase; Amitriptyline; Granule secretion; Phosphatidylserine exposure; Platelets; Thrombin generation; Thrombus formation

Indexed keywords

AMITRIPTYLINE; FLUOXETINE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION;

EID: 84891835630     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300210     Document Type: Article

References (52)

1. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378-3384
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234
3. Jain S, Harris J, Ware J. Platelets: Linking hemostasis and cancer. Arterioscler Thromb Vasc Biol. 2010;30:2362-2367
4. Borst O, Münzer P, Gatidis S, Schmidt EM, Schönberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE, Lang F, Gawaz M. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res. 2012;111:1297-1307
5. Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol. 2010;30:2357-2361
6. Lang PA, Contaldo C, Georgiev P, et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med. 2008;14:756-761
7. Bertozzi CC, Hess PR, Kahn ML. Platelets: Covert regulators of lymphatic development. Arterioscler Thromb Vasc Biol. 2010;30:2368-2371
8. Lang F, Münzer P, Gawaz M, Borst O. Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets. Thromb Haemost. 2013;110:925-930
9. Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol. 2010;30:2341-2349
10. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009;7:1057-1066
11. Borst O, Schmidt EM, Münzer P, Schönberger T, Towhid ST, Elvers M, Leibrock C, Schmid E, Eylenstein A, Kuhl D, May AE, Gawaz M, Lang F. The serum-And glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood. 2012;119:251-261
12. Siljander P, Farndale RW, Feijge MA, Comfurius P, Kos S, Bevers EM, Heemskerk JW. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol. 2001;21:618-627
13. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132
14. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E. Functional inhibitors of acid sphingomyelinase (FIASMAs): A novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9-20
15. Lang F, Gulbins E, Lang PA, Zappulla D, Föller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem. 2010;26:21-28
16. Herz J, Pardo J, Kashkar H, Schramm M, Kuzmenkina E, Bos E, Wiegmann K, Wallich R, Peters PJ, Herzig S, Schmelzer E, Krönke M, Simon MM, Utermöhlen O. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nat Immunol. 2009;10:761-768
17. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9:162-176
18. Goñi FM, Alonso A. Membrane fusion induced by phospholipase C and sphingomyelinases. Biosci Rep. 2000;20:443-463
19. Bhatia R, Matsushita K, Yamakuchi M, Morrell CN, Cao W, Lowenstein CJ. Ceramide triggers Weibel-Palade body exocytosis. Circ Res. 2004;95:319-324
20. Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L, Menna E, Saglietti L, Schuchman EH, Furlan R, Clementi E, Matteoli M, Verderio C. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009;28:1043-1054
21. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T. Involvement of ceramide in hyperosmotic shockinduced death of erythrocytes. Cell Death Differ. 2004;11:231-243
22. Lang PA, Schenck M, Nicolay JP, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med. 2007;13:164-170
23. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol. 1998;18:1523-1533
24. Devlin CM, Leventhal AR, Kuriakose G, Schuchman EH, Williams KJ, Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol. 2008;28:1723-1730
25. Jin S, Zhang Y, Yi F, Li PL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2008;28:485-490
26. Becker KA, Grassmé H, Zhang Y, Gulbins E. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell Physiol Biochem. 2010;26:57-66
27. Gulbins E. Lipids control mucus production in cystic fibrosis. Nat Med. 2010;16:267-268
28. Teichgräber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med. 2008;14:382-391
29. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008;29:381-402
30. Kuebler WM, Yang Y, Samapati R, Uhlig S. Vascular barrier regulation by PAF, ceramide, caveolae, and NO-An intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem. 2010;26:29-40
31. Marathe S, Kuriakose G, Williams KJ, Tabas I. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler Thromb Vasc Biol. 1999;19:2648-2658
32. Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci. 2000;15:85-97
33. Walter S, Fassbender K. Spingolipids in multiple sclerosis. Cell Physiol Biochem. 2010;26:49-56
34. Arboleda G, Huang TJ, Waters C, Verkhratsky A, Fernyhough P, Gibson RM. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur J Neurosci. 2007;25:3030-3038
35. Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, Wiltfang J, Gulbins E. High activity of acid sphingomyelinase in major depression. J Neural Transm. 2005;112:1583-1590
36. Romiti E, Vasta V, Meacci E, Farnararo M, Linke T, Ferlinz K, Sandhoff K, Bruni P. Characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol Cell Biochem. 2000;205:75-81
37. Simon CG Jr, Chatterjee S, Gear AR. Sphingomyelinase activity in human platelets. Thromb Res. 1998;90:155-161
38. Smith EL, Schuchman EH. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008;22:3419-3431
39. Schuchman EH. Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann-Pick disease. FEBS Lett. 2010;584:1895-1900
40. Jin S, Zhou F, Katirai F, Li PL. Lipid raft redox signaling: Molecular mechanisms in health and disease. Antioxid Redox Signal. 2011;15:1043-1083
41. Holopainen JM, Angelova MI, Kinnunen PK. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J. 2000;78:830-838
42. Tani M, Sano T, Ito M, Igarashi Y. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J Lipid Res. 2005;46:2458-2467
43. Stancevic B, Kolesnick R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett. 2010;584:1728-1740
44. Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P. Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One. 2011;6:e23852
45. Lang F, Ullrich S, Gulbins E. Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets. 2011;15:1061-1071
46. Xuan NT, Shumilina E, Kempe DS, Gulbins E, Lang F. Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides. J Neuroimmunol. 2010;219:81-89
47. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem. 2008;283:13538-13548
48. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006;107:3902-3906
49. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193
50. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114:663-666
51. Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombintriggered platelet apoptosis. J Thromb Haemost. 2006;4:2656-2663
52. Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005;202:271-281